Advicenne Pharma   Report issue

For profit Phase 1 Phase 3
Founded: Nimes France (2007)

Organization Overview

First Clinical Trial
2018
NCT03400189
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Advicenne Pharma

Active Ingredients

Drugs in Phase 3 Trials (2)

potassium bicarbonate (4 trials)

potassium citrate (urocit-k) (4 trials)

Drugs in Phase 1 Trials (1)

Sulthiame (Trolone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acidosis (Phase 3)

Acidosis, Renal Tubular (Phase 3)

Cystinuria (Phase 3)

Epilepsy (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3